We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Settings

Save and close

JAX Frontend Platform

Phenotypes of MRL-lpr & MRL Mice

JAX® Mice Strains MRL/MpJ-Faslpr/J & MRL/MpJ

Stock Numbers 000485 & 000486


MRL/MpJ-Faslpr/J mice (MRL-lpr; Strain 000485) develop an autoimmune disease resembling systemic lupus erythematosus (SLE) due to a mutation (Faslpr) that promotes survival of self-reactive lymphocytes, and a strain background (MRL/MpJ;Strain 000486) predisposed to autoimmunity. Both sexes develop disease, although it is accelerated and more severe in females. Disease characteristics in MRL-lpr include:

  • Lymphoproliferation by 16-18 weeks in females and 18-20 weeks in males (Table 1)
  • Progressive renal failure, as indicated by urine albumin:creatinine ratios that increase with age (Table 2)
  • Lymphadenopathy and skin lesions (Table 3)

Table 1 Blood counts. Submandibular blood was collected in EDTA-coated microtainers and analyzed using an Advia 2120 hematology analyzer in a longitudinal study of MRL-lpr and MRL/MpJ control mice. Values indicate the median white blood cell count (x103cells/μL); range and sample sizes are shown in parentheses.

MRL/MpJ-Faslpr/J MRL/MpJ
Age (weeks) Female Male Female Male
6 3.5 (2.5 - 4.8; N=9) 3.3 (2.0 - 3.7; N=9) 5.4 (3.9 - 6.3; N=5) 4.3 (2.5 - 5.4; N=5)
8 3.5 (2.6 - 5.0; N=9) 3.2 (2.1 - 4.2; N=10) 5.4 (4.0 - 6.6; N=5) 4.8 (4.0 - 5.7; N=5)
10 3.8 (2.2 - 4.6; N=9) 3.0 (1.8 - 4.1; N=10) 4.9 (4.6 - 6.3; N=5) 3.7 (3.3 - 6.6; N=5)
12 3.0 (2.2 - 3.9; N=8) 3.7 (2.9 - 5.0; N=10) 5.2 (3.1 - 6.9; N=5) 3.1 (2.8 - 3.9; N=5)
14 4.2 (3.1 - 6.3; N=8) 4.2 (2.8 - 7.3; N=8) 5.0 (3.4 - 6.2; N=5) 4.5 (2.8 - 6.0; N=5)
16 5.5 (3.4 - 14.5; N=8) 4.0 (2.8 - 7.4; N=9) 3.7 (2.7 - 5.4; N=5) 4.9 (3.2 - 6.5; N=5)
18 9.2 (2.2 - 29.5; N=7) 6.1 (3.6 - 9.7; N=9) 4.6 (3.6 - 6.4; N=5) 5.3 (3.2 - 6.2; N=5)
20 9.8 (9.2 - 12.1; N=3) 6.6 (4.1 - 15.8; N=8) 4.0 (2.4 - 5.1; N=5) 3.6 (2.7 - 4.6; N=5)
22 No mice remaining 5.7 (4.2 - 14.6; N=9) 3.7 (2.3 - 4.6; N=5) 3.1 (2.1 - 6.1; N=5)
24 No mice remaining 5.9 (3.4 - 17.1; N=8) 3.7 (2.4 - 4.7; N=4) 4.1 (3.6 - 5.7; N=5)

Table 2 Urinalysis. Urine was analyzed using a Beckman Coulter AU680 chemistry analyzer in a longitudinal study of MRL-lpr and MRL/MpJ control mice. The albumin:creatinine ratios (mg/g) were grouped by age, sex and strain into ranges (< 10, 10 -100, >100). The median values are also provided.

Age (weeks)

Strain

Albumin:Creatinine ratio

5 7 9 11 13 15 17 19 21 23

MRL-lpr Females

Number of mice in range

< 10 3 0 1 0 3 3 0 0 - -
10 - 100 6 9 8 8 3 2 0 0 - -
> 100 1 1 1 1 3 4 8 3 - -
Total # Mice 10 10 10 9 9 9 8 3 - -
Median Ratio 14 28 17 38 57 47 535 957 - -

MRL-lpr Males

Number of mice in range

< 10 3 0 0 0 4 7 0 0 0 0
10 - 100 7 10 10 10 4 1 6 6 4 3
> 100 0 0 0 0 0 1 2 3 5 4
Total # Mice 10 10 10 10 8 9 8 9 9 7
Median Ratio 12 21 26 38 10 0 31 84 110 195

MRL/MpJ Females

Number of mice in range

< 10 0 1 2 1 3 4 0 0 0 0
10 - 100 5 4 3 4 2 0 5 3 3 2
> 100 0 0 0 0 0 0 0 1 0 1
Total # Mice 5 5 5 5 5 4 5 4 3 3
Median Ratio 26 30 13 20 6 0 24 56 24 33

MRL/MpJ Males

Number of mice in range

< 10 0 0 0 1 3 5 0 0 0 1
10 - 100 5 5 5 4 2 0 5 5 5 3
> 100 0 0 0 0 0 0 0 0 0 0
Total # Mice 5 5 5 5 5 5 5 5 5 4
Median Ratio 50 44 22 32 6 0 31 38 39 33

Table 3 Overt signs of disease. Female (F) and male (M) MRL-lpr mice were assessed weekly in a longitudinal study for the presence of enlarged lymph nodes and skin lesions. Columns indicate the percentage of mice displaying the indicated phenotype; rightmost column indicates the number of mice assessed.

Lymphadenopathy Skin Lesions
Cervical Axillary Inguinal Interscapular Ears # Mice
Age (weeks) F M F M F M F M F M F M
Up to 10 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 39 39
11 38% 0% 5% 0% 0% 0% 0% 0% 0% 0% 39 39
12 46% 18% 10% 0% 0% 0% 0% 0% 0% 0% 39 39
13 55% 26% 26% 0% 3% 0% 3% 0% 3% 0% 38 39
14 74% 51% 61% 10% 34% 5% 3% 0% 3% 0% 38 39
15 95% 79% 82% 56% 87% 5% 18% 3% 3% 3% 38 39
16 89% 87% 92% 69% 97% 15% 19% 3% 22% 5% 36 39
17 94% 92% 94% 89% 89% 21% 37% 8% 29% 5% 35 38
18 94% 95% 94% 92% 94% 29% 53% 8% 35% 8% 34 38
19 93% 95% 97% 92% 97% 37% 45% 8% 24% 8% 29 38
20 100% 78% 100% 72% 100% 31% 50% 0% 0% 3% 10 32
21 100% 93% 100% 89% 100% 41% 0% 0% 0% 7% 2 27
22 - 96% - 92% - 88% - 0% - 8% 0 24
23 - 100% - 100% - 91% - 0% - 9% 0 23
24 - 100% - 100% - 90% - 0% - 10% 0 23

©2025 The Jackson Laboratory